Cignarella, Francesca
Filipello, Fabia
Bollman, Bryan
Cantoni, Claudia
Locca, Alberto
Mikesell, Robert
Manis, Melissa
Ibrahim, Adiljan
Deng, Li
Benitez, Bruno A.
Cruchaga, Carlos
Licastro, Danilo
Mihindukulasuriya, Kathie
Harari, Oscar
Buckland, Michael
Holtzman, David M.
Rosenthal, Arnon
Schwabe, Tina
Tassi, Ilaria
Piccio, Laura http://orcid.org/0000-0002-8760-109X
Funding for this research was provided by:
NIA (RF1AG058501)
Alector
Article History
Received: 14 March 2020
Revised: 1 July 2020
Accepted: 6 July 2020
First Online: 9 August 2020
Compliance with ethical standards
:
: IT., T.S., F.C., A.R. and A.I. are Alector employees. L.P. receives research support from Alector. D.M.H. is listed as an inventor on a provisional patent from Washington University on TREM2 antibodies. D.M.H. co-founded and is on the scientific advisory board of C2N Diagnostics. Washington University receives research support from C2N Diagnostics on the use of TREM2 antibodies.